Jiangsu Hengrui Pharmaceuticals Co.,Ltd in 1 story
The narratives 600276.SS currently appears in, with its side and exposure in each.
Bull side
1 story- China Becomes Pharma's Global R&D Engine
600276.SS in “China Becomes Pharma's Global R&D Engine”
FadingExposure: not rated yetWestern drugmakers are licensing clinically validated Chinese molecules rather than relying solely on expensive in-house discovery.
One of China's deepest drug pipelines gives Hengrui a growing inventory of assets that can be licensed to global partners.
Bear side
0 storiesNo bear-side stories for 600276.SS yet.